Diagnostics; making a difference

BIVDA Press Releases

Current Articles | Categories | Search | Syndication

25 November 2015  
BIVDA’s Response to the Spending Review and Autumn Statement
By @ 14:02 :: 124 Views ::

BIVDA's Chief Executive Doris-Ann Williams MBE has responded to the 2015 Spending Review and Autumn Statement.

Read More

11 August 2015  
David Horne announced as President of BIVDA
By @ 11:56 :: 422 Views ::

The British In Vitro Diagnostics Association has appointed David Horne as President of the Association, who takes up office with immediate effect.

Read More

27 July 2015  
Six major projects to bring innovative pathology tests to patients
By @ 12:04 :: 582 Views ::

To support molecular pathology, the MRC and EPSRC have supported six nodes led by the universities of Edinburgh, Glasgow, Leicester, Manchester, Newcastle and Nottingham. Each node brings researchers, clinicians and industry together to develop molecular diagnostic tools, to enable stratification, in disease areas such as cancer, respiratory diseases, digestive disease, infections, rheumatoid arthritis, psoriasis and lupus.

Read More

20 July 2015  
All Party Parliamentary Group established to raise profile of UK Life Sciences sector
By @ 10:48 :: 646 Views ::

Today the new All Party Parliamentary Group (APPG) on Life Sciences holds its official launch event in Parliament. The group has been established to raise awareness and understanding of the valuable contribution the life sciences sector provides to the health and the wealth of the nation.

Read More

28 January 2014  Rebecca Bellars
BIVDA responds to independent review of pathology services in England
By Rebecca Bellars @ 15:44 :: 1848 Views ::

BIVDA welcomes the Pathology Quality Assurance Review; ensuring that we have practices fit for the modern NHS must be a priority, especially if we are going to achieve our ambition to have an NHS that offers the best outcomes to patients each and every day.

Read More

23 January 2014  Rebecca Bellars
Government has made progress delivering Strategy for UK Life Sciences, but there’s more to do, says LifeSciencesUK
By Rebecca Bellars @ 10:23 :: 2587 Views ::

A review of the government’s Strategy for UK Life Sciences has found that eight out of the 13 initiatives reviewed have made notable progress towards the actions and commitments set out in the original strategy, but there is still much more work to do to meet the strategy’s original objectives.

For more information, and to see the report click here. 

Read More

15 August 2013  BIVDA admin
BIVDA's In-house Testing Audit "Safe and consistent? The regulation of pathology testing" is published
By BIVDA admin @ 12:10 :: 2103 Views ::

Safe and consistent? The regulation of pathology testing

An audit of in-house testing and industry recommendations for the future to ensure safety and quality of test results

Read More

03 July 2013  Rachel Myers
BIVDA Regulatory Seminar - Cardiff
By Rachel Myers @ 16:27 :: 2660 Views ::

“Raising your game to meet the next regulatory challenge”

2 & 3 October 2013

at Radisson Blu Hotel, Meridian Gate, Bute Terrace, Cardiff, Wales CF10 3FL

The first EU IVD regulations came into force on 8 December 2003. A survey at the time showed that 38% of IVD manufacturers had still not started the process to register & CE mark their products by the end of 2002. How prepared are you for the new IVD Regulation?

Read More

31 May 2013  BIVDA admin
Diagnostic Evidence Co-operatives
By BIVDA admin @ 10:52 :: 2467 Views ::

The Department of Health (DH) this week announced the allocation of £4 million of funding to analyse the way key diseases are diagnosed within the National Health Service (NHS) and speed up patient access to the best and most effective treatments.

Read More

13 February 2013  BIVDA admin
BIVDA Statement regarding the BMJ press release on Thermofisher’s antimicrobial susceptibility testing discs:
By BIVDA admin @ 09:21 :: 1953 Views ::

As the IVD industry's representative, BIVDA is committed to ensuring the highest standards of safety and quality of in vitro diagnostics in the interests of patients. 

Commercial IVDs used by the NHS, are currently regulated by an EU Directive, which is in UK law under the Consumer Protection Act and which requires continuous vigilance and reporting of product issues to the MHRA by the manufacturer. Additionally, all self-certified CE marked products must have sufficient technical/evaluation data on file and available for independent scrutiny.

BIVDA strongly believes this system is fit for purpose. However, alongside the European organisation, EDMA, BIVDA is an active participant in the current updating of the regulations in the EU.  BIVDA is also is fully committed to working with the Department of Health on the Pathology Quality Assurance Review, announced in December 2012. We will continue to lead the in vitro diagnostic industry in the UK on regulatory and quality issues.

Read More

Previous Page | Next Page